IP Library Patent Application 15553115
Patent Application
App. No. 15/553,115

CELL CULTURE METHOD FOR MESENCHYMAL STEM CELLS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/553,115
Abstract

The present disclosure relates to methods, cell culture medium and compositions that promote cell proliferation during fetal bovine serum free cell culture.

Claims (19)

1 . A method of promoting stem cell proliferation in-vitro, the method comprising: culturing a population of mesenchymal lineage stem cells in a fetal bovine serum free cell culture medium comprising platelet derived growth factor (PDGF) and fibroblast growth factor 2 (FGF2), wherein the level of FGF2 is less than about 6 ng/ml.

2 . A fetal bovine serum free cell culture medium for promoting stem cell proliferation in-vitro comprising:

a basal medium;

platelet derived growth factor (PDGF) fibroblast growth factor 2 (FGF2);

wherein the level of FGF2 is less than about 6 ng/ml.

3 . The method of claim 1 or the culture medium of claim 2 , wherein the level of FGF2 is between at least about 2 pg/ml and 40 pg/ml.

4 . The method of claim 1 or the culture medium of claim 2 , wherein the level of FGF2 is about 20 pg/ml.

5 . The method or culture medium of any one of claims 1 to 4 , wherein the PDGF is PDGF-BB.

6 . The method or culture medium of claim 5 , wherein the level of PDGF-BB is between at least about 3.0 ng/ml and about 120 ng/ml.

7 . The method or culture medium of claim 5 , wherein the level of PDGF-BB is between about 9.0 ng/ml and about 60 ng/ml.

8 . The method or culture medium of claim 5 , wherein the level of PDGF-BB is at least about 30 ng/ml.

9 . The method or culture medium of any one of claims 1 to 8 , wherein the cell culture medium further comprises epidermal growth factor (EGF).

10 . The method or culture medium of claim 9 , wherein the level of EGF is between about 0.08 ng/ml and about 7 ng/ml.

11 . The method or culture medium of claim 9 , wherein the level of EGF is between about 0.4 ng/ml and about 1.6 ng/ml.

12 . The method or culture medium of claim 9 , wherein the level of EGF is at least about 0.8 ng/ml.

13 . The method or culture medium of any one of claims 1 to 12 , wherein the cell culture medium comprises alpha-minimal essential medium or fetal bovine serum free expansion medium.

14 . The method or culture medium of any one of claims 1 to 13 , wherein the cell culture medium maintains the stem cells in an undifferentiated state.

15 . The method or culture medium of any one of claims 1 to 14 , wherein the stem cell is a mesenchymal lineage precursor cell.

16 . The method of any one of claims 1 to 15 , wherein the stem cell is a mesenchymal stem cell.

Assignments (3)
RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT AT REEL/FRAME NO. 45759/0917 Recorded Jul 30, 2025
From: HERCULES CAPITAL, INC., AS AGENT
To: MESOBLAST INTERNATIONAL SARL
Reel/Frame 072297/0753 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Mar 28, 2018
From: MESOBLAST INTERNATIONAL SARL
To: HERCULES CAPITAL, INC., AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 045759/0917 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2018
From: SIMMONS, PAUL; SUIRE, COLBY
To: MESOBLAST INTERNATIONAL SÀRL
Reel/Frame 044730/0727 →